Third-Party Tested ≥98% HPLC Purity — USA Shipped

Research Comparison

5-Amino-1MQ vs NAD+

In Short

5-Amino-1MQ is small-molecule nicotinamide n-methyltransferase (nnmt) inhibitor; NAD+ is pyridine dinucleotide redox coenzyme / enzyme cosubstrate (sirtuin, parp, cd38 substrate). Both are supplied as lyophilized powders for laboratory and in-vitro research use only. The table below compares their molecular data, half-life and research focus side by side.

5-Amino-1MQ NAD+
Classification Small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor Pyridine dinucleotide redox coenzyme / enzyme cosubstrate (sirtuin, PARP, CD38 substrate)
Molecular formula C10H11IN2 C21H27N7O14P2
Molecular weight 286.11 g/mol 663.43 g/mol
CAS number 42464-96-0
Research half-life Not established in published human literature Not well characterized; NAD+ undergoes rapid enzymatic turnover and hydrolytic degradation rather than having a single defined pharmacologic half-life
Primary research focus Metabolic and incretin-pathway research Aging and metabolic health studies
Form Lyophilized powder Lyophilized powder
Price from $37.50 $67.50

5-Amino-1MQ

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that methylates nicotinamide and depletes the cellular pool of S-adenosyl methionine (SAM), a critical methyl donor. By inhibiting NNMT, 5-Amino-1MQ is proposed to increase intracellular NAD+ levels and SAM availability, thereby enhancing cellular energy metabolism and epigenetic regulation. Research published by Neelakantan et al. The same research group at the University of Texas showed that NNMT expression is upregulated in visceral adipose tissue of obese subjects, suggesting the enzyme plays a direct role in metabolic dysfunction. Unlike GLP-1 receptor agonists that suppress appetite centrally, 5-Amino-1MQ operates at the cellular metabolic level by modulating the NAD+ salvage pathway and methylation balance, offering a mechanistically distinct approach. Compared to NMN or NR supplementation (NAD+ precursors), 5-Amino-1MQ addresses NAD+ depletion at the enzymatic level rather than through precursor loading. Studies also suggest NNMT inhibition may improve insulin sensitivity through modulated SIRT1 activity. Store lyophilized powder at -20C protected from moisture; reconstitute in sterile water. This compound is investigated by metabolic biochemistry laboratories, NAD+ biology researchers, and academic institutions studying the intersection of epigenetics and obesity.

Full 5-Amino-1MQ research guide

NAD+

NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme present in every living cell, serving as a critical electron carrier in metabolic redox reactions including glycolysis, the citric acid cycle, and oxidative phosphorylation. Beyond energy metabolism, NAD+ functions as a substrate for sirtuins (SIRT1-7), poly(ADP-ribose) polymerases (PARPs) involved in DNA repair, and CD38/CD157 ectoenzymes involved in calcium signaling. NAD+ levels decline significantly with age, and this decline has been implicated as a driver of metabolic dysfunction and cellular senescence. Seminal research by Imai and Guarente (2014) in Trends in Cell Biology established the NAD+ depletion theory of aging, demonstrating that declining NAD+ levels impair sirtuin activity and mitochondrial function. Studies by Yoshino et al. (2011) in Cell Metabolism showed that NAD+ precursor supplementation restored metabolic function in aged and diet-induced obese mice. Research in Science by Li et al. demonstrated that NAD+ repletion improved muscle stem cell function and extended lifespan in aged murine models through SIRT1-dependent mechanisms. This 500mg formulation provides a direct NAD+ supply for research applications. Compared to precursors like NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside), which require enzymatic conversion, direct NAD+ bypasses biosynthetic pathway bottlenecks, though its larger molecular size presents different cellular uptake considerations. Each approach offers distinct advantages depending on the research model. Store lyophilized NAD+ at -20°C, protected from light and moisture, as it is hygroscopic. Reconstitute with bacteriostatic water and store at 2-8°C, using within 2-3 weeks, as NAD+ is susceptible to hydrolytic degradation in solution. NAD+ is studied by aging researchers, metabolic scientists, DNA repair biologists, and mitochondrial function specialists.

Full NAD+ research guide

Frequently Asked Questions

What is the main difference between 5-Amino-1MQ and NAD+?
5-Amino-1MQ is classified as small-molecule nicotinamide n-methyltransferase (nnmt) inhibitor, while NAD+ is pyridine dinucleotide redox coenzyme / enzyme cosubstrate (sirtuin, parp, cd38 substrate). They are distinct research compounds with different mechanisms — the comparison table above sets out the molecular and pharmacokinetic differences side by side.
Can 5-Amino-1MQ and NAD+ be studied together?
Some research protocols evaluate related peptides in combination, and research blends exist. Combination study design depends entirely on the research question and model. Both compounds are supplied for laboratory and in-vitro research use only — not for human use.
Are 5-Amino-1MQ and NAD+ legal to buy for research?
Both are sold in the United States as research chemicals for laboratory and in-vitro use only. Neither is FDA-approved for human use. Researchers are responsible for compliance with all applicable regulations.

Buy 5-Amino-1MQ

From $37.50 — ≥98% HPLC, COA included.

Buy NAD+

From $67.50 — ≥98% HPLC, COA included.

Research Use Only. This comparison summarizes published research. It is not medical advice. Neither compound is for human consumption or FDA-approved.